Physician profile
Brandy Rene Patterson
NPI 1487771176
$7,432.35
in general payments reported to CMS, 2019-2025
41 companies · $1,489 in 2025
The $1,489 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,540 · 2020: $182 · 2022: $950 · 2023: $554 · 2024: $717 · 2025: $1,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,230 · Honoraria: $350 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,230.33 |
| Honoraria | $350.00 |
| Education | $180.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $3,088.74 | 2019-2020 | |
| Hologic Sales and Service, LLC | $430.97 | 2019-2025 | Acessa Provu System, Aptima, Novasure |
| Abbvie INC. | $426.57 | 2019-2023 | |
| Astellas Pharma US INC | $422.22 | 2019-2025 | Veozah, Myrbetriq |
| Meditrina | $361.31 | 2025 | |
| Sumitomo Pharma America, INC. | $323.28 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $278.10 | 2019-2025 | |
| Pfizer INC. | $258.44 | 2019-2025 | |
| Millicent US INC | $227.84 | 2024-2025 | Intrarosa, Femlyv |
| Organon LLC | $223.30 | 2022-2025 | |
| Myovant Sciences INC. | $126.12 | 2022 | |
| Amgen INC. | $121.37 | 2019-2023 | Prolia, Evenity |
| Coopersurgical, INC. | $99.50 | 2019-2024 | Paragard T 380a, Summit Doppler, Wallach Cryosurgical Equipment |
| Evofem Biosciences, INC. | $72.59 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $71.91 | 2022-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.